Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.
NCT06070376 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2025-05-01
Summary
Esophageal cancer is the seventh most common type of cancer in the world, with an estimated global incidence of 604,100 new cases per year. The main symptom of esophageal cancer is dysphagia, associated or not with weight loss. Unfortunately, due to asymptomatic presentation in the early stages, more than half of patients are diagnosed in advanced stages of the disease, becoming ineligible for treatment with curative intent. In this sense, chemotherapy and radiotherapy are the pillars of palliative treatment, often regressing the injury and improving symptoms. However, some patients persist with dysphagia. In this scenario, esophageal prostheses are one of the main tools in the palliative treatment of esophageal cancer dysphagia, obtaining rapid and lasting relief of dysphagia. This study aims to compare fully covered (FC-SEMS) and partially covered (PC-SEMS) esophageal prostheses in this context, evaluating the number of reinterventions in each group, as well as the occurrence of adverse events. However, it is expected that with the data obtained it is possible to develop clearer and more effective protocols in the palliation of malignant dysphagia of esophageal stenosis.
Conditions
- Esophageal Neoplasms
- Dysphagia
Interventions
- DEVICE
-
Fully Covered Esophageal Prosthesis (FC-SEMS)
The placement of the Fully Covered Esophageal Prosthesis (FC-SEMS) will be performed under sedation or general anesthesia supervised by the anesthesiologist at the endoscopy service of the Cancer Institute of the State of São Paulo (ICESP). The tests will be performed under radioscopic control. The tests will be performed on an outpatient basis, and hospitalization may occur in case of clinical need.
- DEVICE
-
Partially Covered Esophageal Prosthesis (PC-SEMS)
The placement of the Partially Covered Esophageal Prosthesis (PC-SEMS) will be performed under sedation or general anesthesia supervised by the anesthesiologist at the endoscopy service of the Cancer Institute of the State of São Paulo (ICESP). The tests will be performed under radioscopic control. The tests will be performed on an outpatient basis, and hospitalization may occur in case of clinical need.
Sponsors & Collaborators
-
Instituto do Cancer do Estado de São Paulo
lead OTHER
Principal Investigators
-
Fauze Maluf-Filho, PhD · Cancer Institute of the state of São Paulo (ICESP)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-26
- Primary Completion
- 2026-02-26
- Completion
- 2026-08-26
Countries
- Brazil
Study Locations
More Related Trials
-
Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures
NCT01661686 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy Between a Newly Designed Covered Stent and Uncovered Stent for Malignant Colorectal Obstruction
NCT02640781 ·Status: UNKNOWN ·Phase: NA
-
Trial Using 125I Embedded Stent in Patients With Advanced Esophageal Cancer
NCT00826813 ·Status: UNKNOWN ·Phase: NA
-
Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study
NCT06364553 ·Status: RECRUITING ·Phase: NA
-
Esophageal Multisegmented FCSEMS for Malignant Strictures
NCT04415463 ·Status: TERMINATED ·Phase: NA
-
Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction
NCT01646476 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia
NCT01894763 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Polyflex Stenting in Esophageal Cancer Patients
NCT00727376 ·Status: COMPLETED
-
Optimal Management of Malignant Dysphagia
NCT01366833 ·Status: TERMINATED ·Phase: NA
-
A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent
NCT05220475 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction
NCT02937246 ·Status: UNKNOWN ·Phase: NA
-
a Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent
NCT01054274 ·Status: UNKNOWN ·Phase: PHASE3
-
Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction
NCT02255669 ·Status: UNKNOWN ·Phase: NA
-
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
NCT01301495 ·Status: WITHDRAWN ·Phase: PHASE2
-
Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.
NCT02166840 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
NCT01970306 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells
NCT02949414 ·Status: SUSPENDED ·Phase: PHASE1
-
SEMS and Gastroenterostomy
NCT04599179 ·Status: COMPLETED
-
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
NCT03259763 ·Status: COMPLETED ·Phase: NA
-
Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy
NCT02784470 ·Status: UNKNOWN ·Phase: PHASE3
-
Partially Covered and Uncovered Metal Stent for Malignant Distal Biliary Stricture
NCT02178618 ·Status: COMPLETED ·Phase: NA
-
Randomized Trial of Colonic Stents as a Bridge to Surgery
NCT00758186 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
NCT02238847 ·Status: COMPLETED ·Phase: NA
-
cSEMS vs. NEPS in Stricture of Biliary Anastomosis After Liver Transplantation
NCT01393067 ·Status: COMPLETED ·Phase: NA
-
Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer
NCT00477841 ·Status: COMPLETED ·Phase: PHASE2